Literature DB >> 2409016

The human adenoidal mast cell. Susceptibility to different secretagogues and secretion inhibitors.

W Schmutzler, K Delmich, D Eichelberg, S Glück, T Greven, H Jürgensen, K P Riesener, G Risse, P Pult.   

Abstract

Mast cells from adenoid tissues of man do not form a homogeneous population but differ in size and ultrastructure. They degranulate on stimulation with specific antigen, ionophore A 23187, Concanavalin A and, under certain conditions, antihuman IgE or acetylcholine. Compound 48/80, dextran, purified C3a or C5a are ineffective. Adenosine exerts either an enhancing or inhibiting effect on the stimulated histamine release, depending on the actual conditions of the mast cells. The study of a range of known mast cell degranulation inhibitors revealed important differences between human adenoidal mast cells and human basophils or animal mast cell systems. The efficacies of the drugs or drug combinations so far tested correspond well with the established therapeutic effects in man.

Entities:  

Mesh:

Year:  1985        PMID: 2409016     DOI: 10.1159/000233778

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  9 in total

1.  Histamine release from mast cells and monocytes: the effects of azelastine, reproterol and vitamin A-analogues.

Authors:  K Bolsmann; U Braam; D Eichelberg; T Greven; C Jungbluth; W Schmutzler; G Zwadlo-Klarwasser
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

2.  Isolation and sensitivity of human mesenteric mast cells to immunological and nonimmunological histamine releasers.

Authors:  E Brzezińska-Błaszczyk; M Czuwaj
Journal:  Agents Actions       Date:  1987-04

3.  Study of the inhibition of histamine release by inosine pranobex.

Authors:  R Ziesche; D Eichelberg; W Schmutzler
Journal:  Agents Actions       Date:  1987-04

Review 4.  Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

Authors:  S M Grant; K L Goa; A Fitton; E M Sorkin
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

5.  The effects of metoclopramide and cloxacepride on human mast cells from adenoidal tissues.

Authors:  W Schmutzler; T Greven; U Braam
Journal:  Agents Actions       Date:  1989-04

6.  Effects of calmodulin antagonists on human adenoidal mast cells.

Authors:  S Bent; U Braam; W Schmutzler
Journal:  Agents Actions       Date:  1990-04

7.  The influence of H1-, H2- and H3-receptors on the spontaneous and ConA induced histamine release from human adenoidal mast cells.

Authors:  S Bent; U Fehling; U Braam; W Schunack; W Schmutzler
Journal:  Agents Actions       Date:  1991-05

8.  Time-course of the histamine release from human peripheral blood monocytes and the influence of ketotifen and disodium cromoglycate (DSCG).

Authors:  G Zwadlo-Klarwasser; U Braam; C Jungbluth; W Schmutzler
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

9.  Synthetic retinoids inhibit histamine release from isolated human mast cells.

Authors:  D Eichelberg; W Schmutzler
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.